GB/T 44827-2024
ActiveMolecular in vitro diagnostic examinations—Specifications for pre-examination processes in metabolomics in urine, venous blood serum and plasma
分子体外诊断检验 尿液、静脉血清和血浆代谢组学检验前过程的规范
Application Summary AI generated
This standard specifies the pre-examination processes for metabolomics analysis of urine, venous blood serum, and plasma, including sample collection, handling, transport, storage, and processing. It is applied in clinical laboratories and diagnostic facilities conducting molecular in vitro diagnostic tests to ensure the integrity and reproducibility of metabolomic data. The standard is critical for healthcare settings where accurate metabolic profiling is used for disease diagnosis, biomarker discovery, or therapeutic monitoring.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 157-2026
In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.